Google Übersetzer
Crinetics Pharmaceuticals Inc
About
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults
Apr 15 2026
Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer
Apr 8 2026
Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
Mar 26 2026
Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly
Feb 26 2026
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Financials
Revenue
$7.7 M
Market Cap
$3.9 B
EPS
-4.95